
Loading, please wait...

Loading, please wait...

Recent breakthroughs in genomic medicine have deepened our understanding of the relationship between physical activity colorectal cancer (CRC) prevention. While exercise remains a cornerstone of a healthy lifestyle, its protective benefits can vary significantly between individuals based on their unique genetic makeup. Furthermore, scientists are now identifying specific genetic markers that determine how much a person’s risk drops when they stay active.
A massive genome-wide analysis involving over 420,000 individuals has shed new light on this interaction. Researchers analyzed data from 186,157 colorectal cancer cases and 234,675 controls. Consequently, they found that regular exercise generally reduces risk, but specific DNA variants significantly modulate this effect. Specifically, a variant known as rs34460517 on chromosome 6 appears to play a critical role in how the body responds to exercise in the context of cancer prevention.
The study utilized advanced statistical methods, including two-step screening and joint tests, to pinpoint gene-environment interactions. In fact, individuals who were active and carried certain genetic profiles saw a much more pronounced reduction in risk compared to their inactive counterparts. However, this protective association was notably absent or weakened in those with different genotypes at the identified loci. This suggests that the standard \"one-size-fits-all\" exercise recommendation might evolve into personalized preventive strategies in the future.
Moreover, the biological mechanisms involved might relate to inflammatory pathways or insulin signaling. Because physical activity influences metabolic health, these genetic variants likely alter the metabolic response to exertion. For clinicians in India, where colorectal cancer rates are shifting due to lifestyle changes, understanding these nuances is vital. Ultimately, this research underscores the importance of considering both heredity and habits when assessing a patient's long-term health outlook.
No, research indicates that genetic variants like rs34460517 can modify the protective effect of physical activity, meaning some people may experience a greater risk reduction than others.
The study identified a significant interaction at the rs34460517 locus on chromosome 6, which modulates the association between physical activity levels and the risk of developing colorectal cancer.
References
Peoples AR et al. Genetic risk factors modulate the association between physical activity and colorectal cancer. BMC Med. 2026 Feb 05. doi: 10.1186/s12916-026-04675-5. PMID: 41645200.
Zhang X et al. Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study. Br J Cancer. 2021;124(7):1314-1322.
Wang L et al. Physical activity, polygenic risk score, and colorectal cancer risk. Cancer Med. 2022;11(14):2813-2823.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The Synergy of Lifestyle and Genetics in OncologyRecent breakthroughs in genomic medicine have deepened our understanding of the relationship between physic...
8 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today